Enrollees eligible for the new program must be at least 18 years old and meet the following clinical criteria when GLP-1 treatment is started
A novel RET rearrangement (ACBD5/RET) by pericentric inversion, inv(10)(p12.1;q11.2), in papillary thyroid cancer from an atomic bomb survivor exposed to high-dose radiation
is the Monash University Node leader of the ARC Industrial Transformation Training Centre for Cryo-electron Microscopy of Membrane Proteins (CCeMMP) (grant ID: IC200100052), which received support from Novo Nordisk for the current project
however, like any medication, it carries certain risks and side effects
Shifting R&D investments to pipeline candidates, as Novo Nordisk has with oral semaglutide variants, will be crucial to sustaining leadership
Some GLP-1 users, particularly those focused on high-protein, low-fat diets , inadvertently reduce fat intake to levels that contribute to constipation